GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (FRA:C1P) » Definitions » Days Sales Outstanding

Consun Pharmaceutical Group (FRA:C1P) Days Sales Outstanding : 24.02 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Days Sales Outstanding?

Consun Pharmaceutical Group's average Accounts Receivable for the six months ended in Dec. 2023 was €24.9 Mil. Consun Pharmaceutical Group's Revenue for the six months ended in Dec. 2023 was €188.8 Mil. Hence, Consun Pharmaceutical Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 24.02.

The historical rank and industry rank for Consun Pharmaceutical Group's Days Sales Outstanding or its related term are showing as below:

FRA:C1P' s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.49   Med: 59.77   Max: 185.69
Current: 25.98

During the past 12 years, Consun Pharmaceutical Group's highest Days Sales Outstanding was 185.69. The lowest was 25.49. And the median was 59.77.

FRA:C1P's Days Sales Outstanding is ranked better than
90.36% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs FRA:C1P: 25.98

Consun Pharmaceutical Group's Days Sales Outstanding declined from Dec. 2022 (31.99) to Dec. 2023 (24.02).


Consun Pharmaceutical Group Days Sales Outstanding Historical Data

The historical data trend for Consun Pharmaceutical Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Days Sales Outstanding Chart

Consun Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.45 127.88 56.09 30.55 25.87

Consun Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.98 47.27 31.99 29.57 24.02

Competitive Comparison of Consun Pharmaceutical Group's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consun Pharmaceutical Group's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Days Sales Outstanding falls into.



Consun Pharmaceutical Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Consun Pharmaceutical Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (22.103 + 25.052) / 2 ) / 332.643*365
=23.5775 / 332.643*365
=25.87

Consun Pharmaceutical Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (24.664 + 25.052) / 2 ) / 188.845*365 / 2
=24.858 / 188.845*365 / 2
=24.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Consun Pharmaceutical Group  (FRA:C1P) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Consun Pharmaceutical Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Consun Pharmaceutical Group (FRA:C1P) Business Description

Traded in Other Exchanges
Address
71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Consun Pharmaceutical Group (FRA:C1P) Headlines

No Headlines